← Back to Patent Explorer
US6599520B2 Expired / Lapsed US ⏱️ 0.0 years remaining

Method of inducing new bone growth in porous bone sites

Assignee: Warsaw Orthopedic Inc
•
Filing: 2002-03-14
•
Granted: 2003-07-29
•
Expires: 2022-03-14
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method of treating a condition in a vertebrate animal characterized by bone having increased porosity and/or decreased bone mineral density. The porous bone is injected with an effective amount of a flowable bone composition. Also provided is a kit for the treatment of porous bone wherein a flowable bone composition is contained within an injectable delivery system.

Inventors

  • 👤 Nelson L. Scarborough
  • 👤 James Russell

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 01:57
CPC Classifications
A; A61; A61L; A61L27/00; A61L27/36; A61L27/3604; A61L27/3608; A61B; A61B17/00; A61B17/56; A61B17/58; A61B17/68; A61B17/70; A61B17/7061; A61L24/00; A61L24/0005; A61L27/3641; A61L27/3645; A61L27/365; A61L27/3654; A61F; A61F2/00; A61F2/02; A61F2/28; A61L2430/00; A61L2430/38

Claims Analysis

Total Claims: 32
Claim 1
Independent Claim 52 words
A method of treating a condition in a vertebrate animal, the condition characterized by a bone having increased porosity and/or decreased bone mineral density, which comprises injecting the bone with an effective amount of a flowable bone composition, the bone being selected from the group consisting of trabecular bone and cortical bone.
Claim 2
Independent Claim 52 words
A method of treating a condition in a vertebrate animal, the condition characterized by a bone having increased porosity and/or decreased bone mineral density, which comprises injecting the bone with an effective amount of a flowable bone composition, the bone being selected from the group consisting of trabecular bone and cortical bone.
Claim 3
Dependent Claim 32 words
The method of claim 1 wherein the trabecular bone is selected from the group consisting of vertebrae, rib, clavicle, sternum, femoral neck, hip, wrist and the distal ends of the long bones.
Claim 4
Dependent Claim 37 words
The method of claim 1 wherein the condition is selected from the group consisting of osteoporosis, osteomalacia, osteitis fibrosa, Paget's disease, bone deficiency, primary or secondary hyperparathyroidism, chronic inflammatory conditions, metastatic bone disease and osteolytic bone disease.
Claim 5
Dependent Claim 50 words
The method of claim 3 wherein the condition of osteoporosis is selected from the group consisting of age-related osteoporosis, post-menopausal osteoporosis, juvenile osteoporosis, Cushing's syndrome osteoporosis, multiple myeloma osteoporosis, leukemia osteoporosis, Turner's syndrome osteoporosis, alcohol osteoporosis, chronic liver disease osteoporosis, glucocorticoid-induced osteoporosis, chronic inflammatory disease induced osteoporosis and disuse osteoporosis.
Claim 6
Dependent Claim 23 words
The method of claim 1 further comprising administering to the animal one or more agents that promote bone growth and/or inhibit bone resorption.
Claim 7
Dependent Claim 33 words
The method of claim 5 wherein the agent(s) is selected from the group consisting of bone morphogenetic factors, anti-resorption agents, osteogenic factors, cartilage-derived morphogenetic proteins, hormones, growth hormones, genetic material and differentiating factors.
Claim 8
Independent Claim 39 words
A method of vertebroplasty which comprises injecting a vertebra having increased porosity and/or decreased bone mineral density with an effective amount of flowable bone composition, the bone being selected from the group consisting of trabecular bone and cortical bone.
Claim 9
Independent Claim 39 words
A method of vertebroplasty which comprises injecting a vertebra having increased porosity and/or decreased bone mineral density with an effective amount of flowable bone composition, the bone being selected from the group consisting of trabecular bone and cortical bone.
Claim 10
Dependent Claim 31 words
The method of claim 7 wherein the bone is selected from the group consisting of vertebrae, rib, clavicle, sternum, femoral neck, hip, wrist and the distal ends of the long bones.
Claim 11
Dependent Claim 23 words
The method of claim 7 further comprising administering to the animal one or more agents that promote bone growth and/or inhibit bone resorption.
Claim 12
Dependent Claim 33 words
The method of claim 9 wherein the agent(s) is selected from the group consisting of bone morphogenetic factors, anti-resorption agents, osteogenic factors, cartilage-derived morphogenetic proteins, hormones, growth hormones, genetic material and differentiating factors.
Claim 13
Dependent Claim 26 words
The method of claim 1 wherein the bone is provided as a mass of particles ranging in average size from about 0.1 to about 1.2 cm.
Claim 14
Dependent Claim 29 words
The method of claim 11 wherein the bone particles are selected from the group consisting of mineralized bone particles, partially demineralized bone particles, demineralized bone particles and combinations thereof.
Claim 15
Dependent Claim 23 words
The method of claim 1 wherein the flowable bone composition includes a biocompatible liquid material as carrier or suspension agent for the bone.
Claim 16
Dependent Claim 15 words
The method of claim 13 wherein the biocompatible liquid material is glycerol or glycerol solution.
Claim 17
Dependent Claim 26 words
The method of claim 7 wherein the bone is provided as a mass of particles ranging in average size from about 0.1 to about 1.2 cm.
Claim 18
Dependent Claim 29 words
The method of claim 15 wherein the bone particles are selected from the group consisting of mineralized bone particles, partially demineralized bone particles, demineralized bone particles and combinations thereof.
Claim 19
Dependent Claim 23 words
The method of claim 7 wherein the flowable bone composition includes a biocompatible liquid material as carrier or suspension agent for the bone.
Claim 20
Dependent Claim 15 words
The method of claim 17 wherein the biocompatible liquid material is glycerol or glycerol solution.
Claim 21
Independent Claim 74 words
A method of treating a condition in a vertebrate animal, the condition characterized by a bone having increased porosity and/or decreased bone mineral density, which comprises injecting the bone with an effective amount of a flowable bone composition, the bone being selected from the group consisting of cortical bone and trabecular bone selected from the group consisting of vertebrae, rib, clavicle, sternum, femoral neck, hip, wrist and the distal ends of the long bones.
Claim 22
Independent Claim 74 words
A method of treating a condition in a vertebrate animal, the condition characterized by a bone having increased porosity and/or decreased bone mineral density, which comprises injecting the bone with an effective amount of a flowable bone composition, the bone being selected from the group consisting of cortical bone and trabecular bone selected from the group consisting of vertebrae, rib, clavicle, sternum, femoral neck, hip, wrist and the distal ends of the long bones.
Claim 23
Independent Claim 75 words
A method of treating a condition in a vertebrate animal, the condition characterized by a bone having increased porosity and/or decreased bone mineral density, which comprises injecting the bone with an effective amount of a flowable bone composition, the bone being selected from the group consisting of trabecular bone and cortical bone, wherein the flowable bone composition is provided as a mass of particles ranging in average size from about 0.1 to about 1.2 cm.
Claim 24
Independent Claim 75 words
A method of treating a condition in a vertebrate animal, the condition characterized by a bone having increased porosity and/or decreased bone mineral density, which comprises injecting the bone with an effective amount of a flowable bone composition, the bone being selected from the group consisting of trabecular bone and cortical bone, wherein the flowable bone composition is provided as a mass of particles ranging in average size from about 0.1 to about 1.2 cm.
Claim 25
Dependent Claim 29 words
The method of claim 20 wherein the bone particles are selected from the group consisting of mineralized bone particles, partially demineralized bone particles, demineralized bone particles and combinations thereof.
Claim 26
Independent Claim 82 words
A method of treating a condition in a vertebrate animal, the condition characterized by a bone having increased porosity and/or decreased bone mineral density, which comprises injecting the bone with an effective amount of a flowable bone composition, the bone being selected from the group consisting of trabecular bone and cortical bone, wherein the flowable bone composition includes a biocompatible liquid material selected from the group consisting of glycerol and glycerol solution as carrier or suspension agent for the flowable bone composition.
Claim 27
Independent Claim 82 words
A method of treating a condition in a vertebrate animal, the condition characterized by a bone having increased porosity and/or decreased bone mineral density, which comprises injecting the bone with an effective amount of a flowable bone composition, the bone being selected from the group consisting of trabecular bone and cortical bone, wherein the flowable bone composition includes a biocompatible liquid material selected from the group consisting of glycerol and glycerol solution as carrier or suspension agent for the flowable bone composition.
Claim 28
Independent Claim 62 words
A method of vertebroplasty which comprises injecting a vertebra having increased porosity and/or decreased bone mineral density with an effective amount of flowable bone composition, the bone being selected from the group consisting of trabecular bone and cortical bone, wherein the flowable bone composition is provided as a mass of particles ranging in average size from about 0.1 to about 1.2 cm.
Claim 29
Independent Claim 62 words
A method of vertebroplasty which comprises injecting a vertebra having increased porosity and/or decreased bone mineral density with an effective amount of flowable bone composition, the bone being selected from the group consisting of trabecular bone and cortical bone, wherein the flowable bone composition is provided as a mass of particles ranging in average size from about 0.1 to about 1.2 cm.
Claim 30
Dependent Claim 29 words
The method of claim 23 wherein the bone particles are selected from the group consisting of mineralized bone particles, partially demineralized bone particles, demineralized bone particles and combinations thereof.
Claim 31
Independent Claim 69 words
A method of vertebroplasty which comprises injecting a vertebra having increased porosity and/or decreased bone mineral density with an effective amount of flowable bone composition, the bone being selected from the group consisting of trabecular bone and cortical bone, wherein the flowable bone composition includes a biocompatible liquid material selected from the group consisting of glycerol and glycerol solution as carrier or suspension agent for the flowable bone composition.
Claim 32
Independent Claim 69 words
A method of vertebroplasty which comprises injecting a vertebra having increased porosity and/or decreased bone mineral density with an effective amount of flowable bone composition, the bone being selected from the group consisting of trabecular bone and cortical bone, wherein the flowable bone composition includes a biocompatible liquid material selected from the group consisting of glycerol and glycerol solution as carrier or suspension agent for the flowable bone composition.

References Cited (Backward Citations)

US5922753A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2006-07-28 2007-01-27 2007-07-29 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2010-07-28 2011-01-27 2011-07-29 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2014-07-28 2015-01-27 2015-07-29 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag